These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3112849)

  • 1. The voluntary acceptance of HIV-antibody screening by intravenous drug users.
    Carlson GA; McClellan TA
    Public Health Rep; 1987; 102(4):391-4. PubMed ID: 3112849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC; Friedman SR
    AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV infection in intravenous drug dependent patients--Vienna 1988 results].
    Loimer N; Presslich O; Hollerer E; Pfersmann V; Pakesch G; Pfersmann D
    Wien Med Wochenschr; 1989 Jul; 139(14):334-6. PubMed ID: 2788964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS--risk behaviours and AIDS knowledge in intravenous drug users.
    Robinson GM; Thornton NJ; Rout J; Mackenzie N
    N Z Med J; 1987 Apr; 100(821):209-11. PubMed ID: 3455481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To test or not to test: the value of routine testing for antibodies to the human immunodeficiency virus (HIV).
    Stimmel B
    Adv Alcohol Subst Abuse; 1987; 7(2):21-8. PubMed ID: 3482343
    [No Abstract]   [Full Text] [Related]  

  • 6. Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City.
    Selwyn PA; Feiner C; Cox CP; Lipshutz C; Cohen RL
    AIDS; 1987 Dec; 1(4):247-54. PubMed ID: 3126773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of HIV infection in high risk groups in Manipur.
    Singh NB; Singh YI; Singh NC; Singh EK
    J Commun Dis; 1987 Dec; 19(4):373-6. PubMed ID: 3509856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to LAV, the putative agent of AIDS, in parenteral drug abusers and methadone-maintained patients: therapeutic, historical, and ethical aspects.
    Novick DM; Kreek MJ; Des Jarlais DC; Spira TJ; Khuri ET; Ragunath J; Kalyanaraman VS; Gelb AM; Miescher A
    NIDA Res Monogr; 1986; 67():318-20. PubMed ID: 3092085
    [No Abstract]   [Full Text] [Related]  

  • 9. HTLV-III infection in Canada in 1985.
    Neumann PW; Benning BJ; Robinson DG; Gilmore N; O'Shaughnessy MV
    CMAJ; 1986 Sep; 135(5):477-80. PubMed ID: 3461870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
    Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E
    Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness of homosexual and bisexual men in London to be screened for human immunodeficiency virus.
    Welch J; Palmer S; Banatvala JE; Bradbeer C; Barlow D
    Br Med J (Clin Res Ed); 1986 Oct; 293(6552):924. PubMed ID: 3094718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States.
    Strauss SM; Astone JM; Jarlais DD; Hagan H
    Drug Alcohol Depend; 2004 Mar; 73(3):227-36. PubMed ID: 15036545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
    Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M
    CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of HIV-1 infection in Peru, 1986-1990.
    McCarthy MC; Wignall FS; Sanchez J; Gotuzzo E; Alarcon J; Phillips I; Watts DM; Hyams KC
    AIDS; 1996 Sep; 10(10):1141-5. PubMed ID: 8874632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS.
    Lawrinson P; Ali R; Buavirat A; Chiamwongpaet S; Dvoryak S; Habrat B; Jie S; Mardiati R; Mokri A; Moskalewicz J; Newcombe D; Poznyak V; Subata E; Uchtenhagen A; Utami DS; Vial R; Zhao C
    Addiction; 2008 Sep; 103(9):1484-92. PubMed ID: 18636999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-epidemiological patterns of HIV infection in STD patients in Ibadan.
    Ekweozor CC; Olaleye OD; Tomori O; Saliu I; Essien EM; Bakare RA; Oni AA; Oyewo OO; Okesola AO; Onyemenem TN
    Afr J Med Med Sci; 1995 Dec; 24(4):321-7. PubMed ID: 8886145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV antibodies among intravenous drug users in Bahrain.
    al-Haddad MK; Khashaba AS; Baig BZ; Khalfan S
    J Commun Dis; 1994 Sep; 26(3):127-32. PubMed ID: 7868834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.
    Marmor M; Des Jarlais DC; Cohen H; Friedman SR; Beatrice ST; Dubin N; el-Sadr W; Mildvan D; Yancovitz S; Mathur U
    AIDS; 1987 May; 1(1):39-44. PubMed ID: 3122788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HIV infection in provincial prisons in British Columbia.
    Rothon DA; Mathias RG; Schechter MT
    CMAJ; 1994 Sep; 151(6):781-7. PubMed ID: 8087754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.